SHANDONG XINHUA 00719Hong Kong Stock Exchange

5.6900.44%( +0.025 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
SHANDONG XINHUA (00719) Company Profile - Company Info, Industry & Management - cibo

Company Information

Market
HKEX Main Board
Listing Date
1996-12-31
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
CNE100000411
Southbound Connect
Shanghai · Shenzhen

Related Securities

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)10.27B18/112
Net Profit (Last FY)339.94M33/125
ROE (Last FY)5.57%43/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
Zhang Chengyong Non-Executive Director
He Tongqing Independent Non-Executive Director
Xu Wenhui Independent Non-Executive Director
Hou Ning Independent Non-Executive Director
Pan Guangcheng Independent Non-Executive Director
Zhu Jianwei Independent Non-Executive Director
Ling Peixue Independent Non-Executive Director
Cheung Ching Ching, Daisy Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-03-31.

About this page

This page shows SHANDONG XINHUA (00719) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.